Latest News

Elixirgen Signs License Agreement with National Institute on Aging

Elixirgen Announces License Agreement with Sumitomo Dainippon Pharma

New Down syndrome therapy discovered

Elixirgen awarded Investigator-Initiated Grant from MSCRF